Close



Apr 10, 2024 08:11AM
Apr 10, 2024 08:11AM
Mar 20, 2024 08:31AM
Mar 20, 2024 08:30AM
Mar 18, 2024 07:15AM
Mar 18, 2024 07:15AM
Feb 28, 2024 08:25AM Silo Pharma (SILO) Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
Feb 28, 2024 08:25AM
Feb 14, 2024 08:45AM
Feb 14, 2024 08:45AM
Feb 1, 2024 10:00AM
Jan 4, 2024 08:55AM
Dec 28, 2023 08:26AM
Dec 28, 2023 08:25AM Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
Nov 21, 2023 08:02AM
Nov 21, 2023 08:01AM
Nov 8, 2023 08:11AM
Oct 11, 2023 08:35AM
Sep 20, 2023 08:28AM
Sep 20, 2023 08:28AM
Sep 12, 2023 08:50AM Silo Pharma (SILO) Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
Sep 12, 2023 08:50AM
Aug 10, 2023 08:50AM
Jun 23, 2023 09:00AM
Apr 24, 2023 08:15AM
Apr 24, 2023 08:15AM
Mar 27, 2023 09:02AM
Mar 27, 2023 09:00AM Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
Mar 27, 2023 09:00AM
Mar 15, 2023 08:40AM
Mar 15, 2023 08:40AM
Mar 15, 2023 08:40AM
Dec 1, 2022 09:01AM
Dec 1, 2022 09:00AM
Nov 11, 2022 08:15AM Silo Pharma, Inc. (SILO) Achieves New Milestone for SP-26 Therapeutic
Nov 11, 2022 08:15AM
Nov 11, 2022 08:15AM
Oct 20, 2022 08:07AM
Oct 20, 2022 08:05AM
Oct 20, 2022 08:05AM
Oct 10, 2022 08:05AM
Oct 10, 2022 08:05AM Silo Pharma Initiates Toxicity Study of its Proprietary Ketamine Formulation for Treatment of Fibromyalgia
Oct 3, 2022 09:47AM
Oct 3, 2022 09:47AM
Oct 3, 2022 09:47AM
Jul 12, 2021 08:09AM
Jul 12, 2021 08:08AM
Sep 28, 2020 09:14AM

251,413 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All